PF-06873600 is a selective and orally bioavailable inhibitor of cyclin-dependent kinase (CDK)
4)33)26-13-14-27-23(10-7-16-30(26
5)43(42(54)65)73-32(54)17-53(9)25(26)10-11-30-50(6)14-13-31(51(7
CEP-40783 in combination with erlotinib demonstrate superior anti-tumor efficacy compared to CEP-40783 and erlotinib single agents in the one erlotinib-sensitive model evaluated
L-Glucose Catalog No.:M28261-C PF-06873600 is a selective andL Glucose (L ( ) Glucose) is an enantiomer of D glucose. L Glucose can promote food intake. Product information CAS Number: 921 60 8 Molecular Weight: 180. 16 Formula: C6H12O6 Chemical Name: (2S,3R,4S,5S) 2,3,4,5,6 pentahydroxyhexanal Smiles: OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)C=O InChiKey: GZCGUPFRVQAUEE VANKVMQKSA N InChi: InChI=1S C6H12O6 c7 1 3(9)5(11)6(12)4(10)2 8 h1,3 6,8 12H,2H2 t3 ,4+,5+,6+ m1 s1 Technical Data Appearance: Solid Power Purity: